The Library
Potential effects of commonly applied drugs on neural stem cell proliferation and viability : a hypothesis-generating systematic review and meta-analysis
Tools
Tools
Tools
Mortimer, Katherine R. H., Vernon-Browne, Hannah, Zille, Marietta, Didwischus, Nadine and Boltze, Johannes (2022) Potential effects of commonly applied drugs on neural stem cell proliferation and viability : a hypothesis-generating systematic review and meta-analysis. Frontiers in Molecular Neuroscience, 15 . 975697. doi:10.3389/fnmol.2022.975697 ISSN 1662-5099.
|
PDF
WRAP-potential-effects-commonly-applied-drugs-neural-stem-cell-proliferation-viability-2022.pdf - Published Version - Requires a PDF viewer. Available under License Creative Commons Attribution 4.0. Download (2293Kb) | Preview |
Official URL: https://doi.org/10.3389/fnmol.2022.975697
Abstract
Neural stem cell (NSC) transplantation is an emerging and promising approach to combat neurodegenerative diseases. While NSCs can differentiate into neural cell types, many therapeutic effects are mediated by paracrine, “drug-like” mechanisms. Neurodegenerative diseases are predominantly a burden of the elderly who commonly suffer from comorbidities and thus are subject to pharmacotherapies. There is substantial knowledge about drug-drug interactions but almost nothing is known about a potential impact of pharmacotherapy on NSCs. Such knowledge is decisive for designing tailored treatment programs for individual patients. Previous studies revealed preliminary evidence that the anti-depressants fluoxetine and imipramine may affect NSC viability and proliferation. Here, we derive a hypothesis on how commonly applied drugs, statins and antihypertensives, may affect NSC viability, proliferation, and differentiation. We conducted a systematic review and meta-analysis looking at potential effects of commonly prescribed antihypertensive and antihyperlipidemic medication on NSC function. PubMed and Web of Science databases were searched on according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Publications were assessed against a priori established selection criteria for relevancy. A meta-analysis was then performed on data extracted from publications eligible for full text review to estimate drug effects on NSC functions. Our systematic review identified 1,017 potential studies, 55 of which were eligible for full text review. Out of those, 21 were included in the qualitative synthesis. The meta-analysis was performed on 13 publications; the remainder were excluded as they met exclusion criteria or lacked sufficient data to perform a meta-analysis. The meta-analysis revealed that alpha-2 adrenoceptor agonists, an anti-hypertensive drug class [p < 0.05, 95% confidence intervals (CI) = –1.54; –0.35], and various statins [p < 0.05, 95% CI = –3.17; –0.0694] had an inhibiting effect on NSC proliferation. Moreover, we present preliminary evidence that L-type calcium channel blockers and statins, particularly lovastatin, may reduce NSC viability. Although the data available in the literature is limited, there are clear indications for an impact of commonly applied drugs, in particular statins, on NSC function. Considering the modes of action of the respective drugs, we reveal plausible mechanisms by which this impact may be mediated, creating a testable hypothesis, and providing insights into how future confirmative research on this topic may be conducted.
| Item Type: | Journal Article | ||||||
|---|---|---|---|---|---|---|---|
| Subjects: | Q Science > QH Natural history Q Science > QP Physiology R Medicine > RC Internal medicine R Medicine > RM Therapeutics. Pharmacology R Medicine > RS Pharmacy and materia medica |
||||||
| Divisions: | Faculty of Science, Engineering and Medicine > Science > Life Sciences (2010- ) | ||||||
| SWORD Depositor: | Library Publications Router | ||||||
| Library of Congress Subject Headings (LCSH): | Neural stem cells , Hypotensive agents , Statins (Cardiovascular agents) , Drug delivery systems, Cell proliferation | ||||||
| Journal or Publication Title: | Frontiers in Molecular Neuroscience | ||||||
| Publisher: | Frontiers Media S.A. | ||||||
| ISSN: | 1662-5099 | ||||||
| Official Date: | 5 October 2022 | ||||||
| Dates: |
|
||||||
| Volume: | 15 | ||||||
| Article Number: | 975697 | ||||||
| DOI: | 10.3389/fnmol.2022.975697 | ||||||
| Status: | Peer Reviewed | ||||||
| Publication Status: | Published | ||||||
| Access rights to Published version: | Open Access (Creative Commons) | ||||||
| Date of first compliant deposit: | 31 October 2022 | ||||||
| Date of first compliant Open Access: | 31 October 2022 |
Request changes or add full text files to a record
Repository staff actions (login required)
 |
View Item |
Downloads
Downloads per month over past year
